Journal Club - PowerPoint PPT Presentation

1 / 21
About This Presentation
Title:

Journal Club

Description:

5yo girl comes to clinic with multiple firm, fleshy lesions over her shoulder, neck and chin. ... Exclusion: immunocompromised, severe eczema. Are the results valid? ... – PowerPoint PPT presentation

Number of Views:59
Avg rating:3.0/5.0
Slides: 22
Provided by: tamikab
Category:

less

Transcript and Presenter's Notes

Title: Journal Club


1
Journal Club
  • September 11, 2006
  • Tamika Brierley, MD

2
Our patient. . .
  • 5yo girl comes to clinic with multiple firm,
    fleshy lesions over her shoulder, neck and chin.
    Some of the lesions are umbilicated. Others are
    excoriated.

3
(No Transcript)
4
(No Transcript)
5
Our patient, continued. . .
  • You explain to the mother that these lesions are
    molluscum contagiosum, caused by a virus. You
    discuss the etiology and natural history of the
    rash, explaining that it may take months, but the
    rash will ultimately resolve on its own.
  • She inevitably says, yes, but isnt there
    something you can do to make it go away faster???

6
Clinical Question
  • Is there a topical treatment that can speed the
    resolution of molluscum contagiosum lesions?

7
Search
  • PubMed
  • Search molluscum contagiosum
  • Limits all children (0-18 years), published in
    the past 2 years, clinical trial or randomized
    control trial, English, Human
  • Resulted in 3 articles

8
  • K.S. Leslie, G. Dootson and J. C. Sterling.
    Topical salicylic acid gel as a treatment for
    molluscum contagiosum in children. Journal of
    Dermatological Treatment. 2005 16 336-340.

9
Participants
  • Children were referred from local general
    practitioners and pediatricians, trial conducted
    by outpatient dermatology clinics at a teaching
    hospital and a district general hospital
  • 114 children were enrolled over a 4 year period
  • Inclusion multiple MC lesions, parental consent
  • Exclusion immunocompromised, severe eczema

10
Are the results valid?
  • Randomized to one of three groups salicylic
    acid, phenol or vehicle
  • Groups were similar at beginning of trial
  • Participants sought treatment for similar reasons

11
Leslie, et al. Journal of Dermatological
Treatment, 2005.
12
Leslie, et al. Journal of Dermatological
Treatment, 2005.
13
Are the results valid?
  • Single blinded for phenol and vehicle, no
    blinding for salicylic acid group
  • Patients were treated in the clinic monthly
    (phenol and vehicle) salicylic acid also had
    monthly visits but were treated 1-2 x/ week at
    home
  • All patients were given an aqueous moisturizer
    cream
  • Participants were followed until resolution or to
    6 months, whichever came first
  • Both an intention to treat and an as treated
    analysis were performed

14
Leslie, et al. Journal of Dermatological
Treatment, 2005.
15
Results
  • Resolution of all lesions
  • 16 of 36 ( 44.4 ) with vehicle
  • 17 of 41 (41.5 ) with phenol
  • 21 of 37 (56.8 ) with salicylic acid
  • No significant differences between groups
  • When analyzed as treated, statistical
    difference between phenol and salicylic acid
    groups only

16
Time to Resolution
Leslie, et al. Journal of Dermatological
Treatment, 2005.
17
Treatment Effect
  • Phenol vs. Salicylic Acid
  • RRR 26, ARR 0.15, NNT 7
  • ARR CI -0.08 - 0.38
  • NNT CI 3 - infinity
  • Vehicle vs. Salicylic Acid
  • RRR 22, ARR 0.12, NNT 8
  • ARR CI -0.07 - 0.35
  • NNT CI 3 - infinity

18
Calculations
  • RRR CER EER / CER
  • ARR CER EER
  • NNT 1 / ARR
  • CI were calculated using the CATmaker stats
    program from the Oxford Centre for Evidence Based
    Medicine
  • http//www.cebm.net/toolbox.asp

19
Adverse Events
  • No serious adverse effects
  • All patients were asked about tolerability of
    treatment at first follow-up
  • 0 vehicle, 2 phenol, and 5 salicylic acid
    patients chose to discontinue treatment
  • Remainder found the treatment tolerable or
    fine

20
Utility
  • Can the results be applied to my patient?
  • Yes
  • Were all clinically relevant outcomes considered?
  • No analyze time to resolution
  • Are the treatment benefits worth the potential
    harms and costs?
  • Yes

21
Thanks!
  • Rachel Chapman
Write a Comment
User Comments (0)
About PowerShow.com